MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
Microbot Medical EV - Enterprise Value 2011-2026 | MBOT
Annual EV - Enterprise Value Microbot Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 M | 40.4 M | 13.1 M | 16.6 M | 28.1 M | 41.1 M | 15 M | 23.7 M | 24.6 M | 68.3 M | 54.6 M | 96 M | 89.2 M | 56.1 M | 15.9 M | 204 B | -38.6 M | -30 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 204 B | -38.6 M | 11.4 B |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICU Medical
ICUI
|
3.36 B | $ 129.31 | 4.57 % | $ 3.19 B |  USA |
 |
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | USA |
 |
Intuitive Surgical
ISRG
|
170 B | $ 449.03 | 1.69 % | $ 160 B | USA |
 |
The Cooper Companies
COO
|
20.4 B | $ 61.75 | 0.49 % | $ 12.3 B | USA |
 |
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
201 M | $ 4.0 | 1.01 % | $ 185 M | USA |
 |
Alcon
ALC
|
7.99 B | $ 67.28 | 1.51 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
2.73 B | $ 101.43 | 0.1 % | $ 2.3 B | USA |
 |
Masimo Corporation
MASI
|
10.4 B | $ 178.79 | -0.01 % | $ 9.53 B | USA |
 |
iRhythm Technologies
IRTC
|
5.71 B | $ 117.0 | 2.78 % | $ 3.74 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | USA |
 |
Milestone Scientific
MLSS
|
27.7 M | $ 0.4 | 14.99 % | $ 32.8 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
36 M | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
13.4 M | $ 6.13 | 3.81 % | $ 52 K | USA |
 |
Envista Holdings Corporation
NVST
|
3.62 B | $ 23.77 | 3.12 % | $ 3.99 B | USA |
 |
Haemonetics Corporation
HAE
|
2.76 B | $ 59.56 | 4.77 % | $ 3 B | USA |
 |
STERIS plc
STE
|
27.5 B | $ 215.97 | 0.72 % | $ 21.3 B | USA |
 |
Isoray
ISR
|
29.3 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
4.69 B | $ 143.82 | 2.8 % | $ 6.97 B | USA |
 |
Utah Medical Products
UTMD
|
117 M | $ 64.17 | 0.27 % | $ 208 M | USA |
 |
STAAR Surgical Company
STAA
|
895 M | $ 33.05 | 1.38 % | $ 1.64 B | USA |
 |
InfuSystem Holdings
INFU
|
157 M | $ 10.16 | 5.07 % | $ 210 M | USA |
 |
Teleflex Incorporated
TFX
|
8.89 B | $ 135.18 | 1.84 % | $ 6.03 B | USA |
 |
Merit Medical Systems
MMSI
|
5.51 B | $ 64.49 | 1.13 % | $ 3.82 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 9.84 | 1.03 % | $ 1.96 B | USA |
 |
West Pharmaceutical Services
WST
|
17.9 B | $ 305.5 | 0.52 % | $ 22.1 B | USA |
 |
Pulse Biosciences
PLSE
|
1.64 B | $ 26.09 | 4.57 % | $ 1.76 B | USA |
 |
Retractable Technologies
RVP
|
85.7 M | $ 0.66 | -2.35 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
175 M | $ 63.47 | 4.43 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
989 M | $ 24.0 | 4.12 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
191 M | $ 1.85 | 6.94 % | $ 168 M | USA |
 |
Baxter International
BAX
|
21.6 B | $ 18.77 | 2.4 % | $ 9.63 B | USA |
 |
ResMed
RMD
|
36.5 B | $ 209.86 | 1.0 % | $ 30.7 B | USA |
 |
AtriCure
ATRC
|
1.55 B | $ 29.0 | 0.69 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
78.6 M | $ 5.4 | 7.78 % | $ 240 M | USA |
 |
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
396 M | $ 11.81 | 3.23 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.5 B | $ 146.95 | - | $ 42.3 B | USA |
 |
Nephros
NEPH
|
31.3 M | $ 3.57 | -1.79 % | $ 37.9 M | USA |
 |
OraSure Technologies
OSUR
|
98.2 M | $ 3.07 | -0.32 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
284 M | $ 111.74 | 2.97 % | $ 6.28 M | USA |